Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 30Oropharyngeal Neoplasms 21Nasopharyngeal Carcinoma 16Head and Neck Neoplasms 13Prostatic Neoplasms 12Laryngeal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Carcinoma, Squamous Cell 8Carcinoma 8Breast Neoplasms 8Rectal Neoplasms 7Mouth Neoplasms 7Hypopharyngeal Neoplasms 7Glioma 6Glioblastoma 6Uterine Cervical Neoplasms 5Papillomavirus Infections 5Esophageal Neoplasms 5Urinary Bladder Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Nasopharyngeal Neoplasms 4Astrocytoma 4Mesothelioma, Malignant 3Lymphatic Metastasis 3Lung Neoplasms 3Leukemia, Myeloid, Acute 3Endometrial Neoplasms 3Brain Neoplasms 3Tumor Virus Infections 2Tongue Neoplasms 2

Interventions

Radiotherapy, Intensity-Modulated 1Immune Checkpoint Inhibitors 1Cisplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nasopharyngeal Cancinoma (NPC) × Radiotherapy, Intensity-Modulated × 1 year × Clear all
NCT07238569 2025-11-20

Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 3 Not yet recruiting
516 enrolled
Head & Neck

Nasopharyngeal Cancinoma (NPC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡